Trial Profile
Trans Retinoic Acid (Vesanoid) With Chemotherapy in Non-Small Cell Lung Cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tretinoin (Primary) ; Cisplatin; Mitomycin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2005 New trial record.